Biotech2050 Podcast

Biotech2050 Podcast is a think tank chronicling the disruptions changing the biotech industry over the next 50 years. Hosted by @rahulc and @aloktayi

[Biotech2050 Podcast @Biotech2050Pod]

What does patient-centricity look like when embedded in C-suite?
@ardelyx CEO Mike Raab & Chief Patient Officer Laura Williams join @rahulc to share lessons on leadership, perseverance, patient advocacy, & navigating the FDA journey. 🧬❤️ 🎧 - https://t.co/5mDRCfOBT5 #Biotech2050

[Biotech2050 Podcast @Biotech2050Pod]

How do you go from pharmacist to leading a billion-dollar biotech? Catherine Owen Adams, CEO of @AcadiaPharma, joins @rahulc on #Biotech2050 to discuss neuro & rare disease innovation, commercialization, AI, & first-time CEO lessons. 🧠 🎙️- https://t.co/y36mZmKYFB

[Biotech2050 Podcast @Biotech2050Pod]

This episode is sponsored by @Quartzy.
Barry Quart, CEO of Connect Biopharma, joins @aloktayi on #Biotech2050 to discuss IL-4 biology, ER-based innovation, biotech funding realities & cross-border strategy in a complex global market. 🧬📊🌍 #Biotech #Asthma #COPD #Biologics

[Biotech2050 Podcast @Biotech2050Pod]

This episode is sponsored by @Quartzy.
Sheila Gujrathi, MD joins @rahulc on #Biotech2050 to discuss leadership, venture building, & lessons from her book The Mirror Effect on confidence, leadership & navigating power in biotech
🎧 https://t.co/JRceKwL7KY
#TheMirrorEffect #biotech

[Biotech2050 Podcast @Biotech2050Pod]

@aloktayi talks with @BHilberdink, President, U.S. Human Pharma at @Boehringer, on launching at scale, AI-driven commercial strategy, obesity, rare disease & building pharma for generations. #Biotech2050 #LifeSciences 🧬🤖
▶️ - https://t.co/settEJ7e3G
🎙️ - https://t.co/zPJqkqurMa

[Biotech2050 Podcast @Biotech2050Pod]

Recorded at JPM 2026: @aloktayi speaks with Lundbeck EVP, R&D Johan Luthman on rebuilding neuroscience pipelines, Alzheimer’s breakthroughs, rare disease strategy & AI-driven R&D. A masterclass in disciplined drug development. 🧠🚀 #Biotech2050
🎧 - https://t.co/eJx0AABUJn

[Biotech2050 Podcast @Biotech2050Pod]

How do you build a $2B biotech without losing sight of the patient?
@LEOHealthySkin CEO Christophe Bourdon joins @aloktayi on #Biotech2050 to discuss dermatology innovation, rare disease execution, AI-driven scouting & why “me-too” drugs aren’t enough 🎧 - https://t.co/Ku0y90plOM

[Biotech2050 Podcast @Biotech2050Pod]

This episode is sponsored by @Quartzy.
How do you turn Phase 3 wins into durable biotech value?
@Roivant CEO @gline joins @rahulc on #Biotech2050 to discuss clinical breakthroughs, capital discipline & building biotech that lasts. 📊 🧬
🎧 Listen: https://t.co/EsuORHwFhn

[Biotech2050 Podcast @Biotech2050Pod]

Sponsored by @Quartzy
Cancer doesn’t fight fair—so @DiakonosOnc rewrote the immune playbook
Jay Hartenbach joins @aloktayi to reveal how dual-loaded dendritic cells trigger viral level immune attacks in GBM, pancreatic cancer & melanoma 🧬
🎧 https://t.co/kEFPlWJHMY
#Biotech2050

[Biotech2050 Podcast @Biotech2050Pod]

The episode is sponsored by @Quartzy.
🔬 “What if we’ve only mapped a fraction of human proteins?”
@rahulc interviews John Lepore, CEO of @ProFoundTx, on AI, risk-taking, & the next frontier of first-in-class medicines powered by the expanded proteome.
🎧 https://t.co/4g8eX9oD6v

[Biotech2050 Podcast @Biotech2050Pod]

Biotech needs a systems reboot. 🧬
Host @aloktayi talks with @jrkelly, CEO & Co-Founder of @Ginkgo, about automation, AI-ready data, fixing drug dev economics, & why now is still a great time to start a biotech.
Listen: https://t.co/WjrJ91AaYR
#Biotech2050 #AIinBiotech

[Biotech2050 Podcast @Biotech2050Pod]

@CoyaTx CEO Arun Swaminathan joins @aloktayi for a powerful deep dive into Treg-modulating science, ALS & FTD progress, & the real mechanics of high-impact biotech partnerships. A systems-level masterclass in modern drug development
🎧 Listen: https://t.co/jl9AWB0MTH
#Biotech2050

[Biotech2050 Podcast @Biotech2050Pod]

🧬 New #Biotech2050 episode with @AbbasRKazimi, CEO of @NimbusTx.
He joins @aloktayi to talk founder mentality, “love the portfolio” decision-making, embracing attrition, and leading calmly through FDA shifts, geopolitics & funding uncertainty.
Listen 👉 https://t.co/wqernkMApT

[Biotech2050 Podcast @Biotech2050Pod]

💸 Interest rates 🤖 AI 🧠 Human insight
All shaping the future of biotech.
🎙️ @JTananbaum, Founder & CEO of @foresitecapital, joins @rahulc on #Biotech2050 to unpack venture cycles, AI’s rise in drug discovery, & next wave of innovation.
🎧 Listen now →https://t.co/5n6uSVZnEz

[Biotech2050 Podcast @Biotech2050Pod]

Biotech’s next wave is polymer-powered. 💥 @rahulc talks w/ Geoffrey Duyk, CEO of Grove Biopharma, on tackling “intractable” targets, fixing R&D inefficiency, & rebuilding trust in science. 🎧 Listen and learn more: https://t.co/ie5pVoxfvl
#Biotech2050 #DrugDiscovery #Innovation

[Biotech2050 Podcast @Biotech2050Pod]

Thrilled to share that our very own host, @rahulc, joins the panel at @SyneosHealth’s Heart of Health during #FierceBiotechWeek 🧬💬
Powerful insights on innovation, empathy & the future of biotech.
🔗 Check it out: https://t.co/BM3AyfayoJ
#HeartOfHealth #Biotech2050

[Biotech2050 Podcast @Biotech2050Pod]

#Biotech2050 Episode sponsored by @MeetClora 🌟 #Biotech thrives on co-creation. @rahulc talks w/ @PaulBiondi9 (@FlagshipPioneer) & Uli Stilz (@novonordisk) on trust, innovation & partnerships driving breakthroughs in obesity & diabetes. 🎧 https://t.co/t6DRsySf2y
#DrugDiscovery

[Biotech2050 Podcast @Biotech2050Pod]

A must-listen🎙️ @rahulc chats w/ @KevinCaldweII, CEO of @OssiumHealth, on building a vertically integrated cell therapy platform, scaling immune health, & leading with bold vision. From astrophysics to biotech innovation 🚀
Listen: https://t.co/lGBnH6A6zW
#Biotech2050 #StemCells

[Biotech2050 Podcast @Biotech2050Pod]

#Biotech2050 Episode is sponsored by @MeetClora
Can a blood test change how we detect & treat cancer? 💉 @GuardantHealth Co-CEO @AmiraliTalasaz joins @rahulc to talk liquid biopsy, $3B+ raised, biotech grit & urgency in oncology. Listen: https://t.co/0EBYG3tJIZ #LiquidBiopsy

[Biotech2050 Podcast @Biotech2050Pod]

New #Biotech2050 🎧: @amylburroughs, CEO of @TernsPharma, talks with @aloktayi about advancing CML & obesity therapies, data readouts ahead, & lessons from Genentech, P&G & her CEO journey. Grit, science & leadership in one episode. Listen→ https://t.co/ufqs67u8DM #GLP1 #Biotech